We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 0.61% | 1,649.50 | 1,648.50 | 1,649.00 | 1,656.00 | 1,644.50 | 1,650.50 | 715,719 | 11:39:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.77 | 67.87B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/12/2022 14:33 | Many people heavily criticized GSK for not producing an emergency response vaccine for Covid. I think history could show it as the best decision they never made:- Dr John Campbell's reaction at the end says it all! | jonjoneil | |
12/12/2022 15:35 | May attract a predator before this apparent unnecessary spend? | alphorn | |
12/12/2022 15:21 | Better to invest in R&D? GSK announces new global headquarters in central London. Pharmaceuticals firm GSK has announced it will build a new headquarters in central London. The company will move to the new headquarters in 2024, on the corner of New Oxford Street and Earnshaw Street, from its current location in Brentford, West London. Reminds of the days of the infamous 'Glaxo Air force'. | alphorn | |
12/12/2022 12:27 | Heading back to pre court win levels | spoole5 | |
09/12/2022 16:10 | Whoops, meant '307 | rikky72 | |
09/12/2022 16:09 | I'm more inclined to agree with post '312. Don't forget they had a couple of considerable pipeline setbacks in the last few months. They now need some good news stories in that area! | rikky72 | |
09/12/2022 16:08 | And Californians ! | abdullla | |
09/12/2022 16:06 | I think the high court ruling by the judge is going to be appealed and the game is ON again backed by Florida's ! | abdullla | |
09/12/2022 15:55 | Any reason why it's down over last 2 days | alibizzle | |
09/12/2022 14:42 | It is slightly amusing to think so many whizz kids in US and UK might have gotten caught short in this stock and since the courtroom results, they have to spend their entire time trying to talk it down.... I wonder what bollx they will try to come up with next.😃ԅ | netcurtains | |
09/12/2022 12:29 | I think the message is that what's holding GSK back was never really Zantac, that's just a temporary blip thing. The real problem is their long term poor performance. | anhar | |
09/12/2022 08:42 | Hard to swallow why markets panicked over Zantac It’s too soon to say the great Zantac panic – the one that clobbered GlaxoSmithKline&rsqu | zho | |
09/12/2022 08:21 | 1600 starting to look like a great exit opportunity! | spoole5 | |
08/12/2022 10:49 | From a high of almost £16 yday to £14.70 now , it's the GSK rollercoaster! | alibizzle | |
08/12/2022 10:49 | sold at 1560 when to buy back? or maybe buy WWH instead | phillis | |
08/12/2022 09:38 | ..so, once it sinks in, it looks like it will settle around £16-£17 over the next month or two. £18 once California court 'wins' come through. When should we expect good news from California? | netcurtains | |
08/12/2022 09:37 | Price drop could be due to,speculative,losin | abdullla | |
08/12/2022 09:34 | If there was bad news about Zantac this would go down for days! With good news couldn't hold £15 | mj19 | |
08/12/2022 09:18 | Speculation sells ! | abdullla | |
07/12/2022 20:04 | ..so, once it sinks in, it looks like it will settle around £16-£17 over the next month or two. £18 once California court 'wins' come through. | netcurtains | |
07/12/2022 19:45 | Ah ok it just last night it said up $3 around 10% | alibizzle | |
07/12/2022 19:29 | I think it's just coming off the 16 quid highs we saw over here at 8.00 am and is in line with the UK close. | stewart64 | |
07/12/2022 19:26 | Just says down 3% | alibizzle |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions